CDD patient-derived neurons differentiated from induced pluripotent stem cells (iPSCs) provide a valuable alternative approach to identification of new CDKL5 targets since the samples are derived from the affected cell type, human brain neurons. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.